Valsartan attenuated oxidative stress, decreased MCP-1 and TGF-β1 expression in glomerular mesangial and epithelial cells induced by high-glucose levels
Authors:
- 1 January 2011
- journal article
- Published by International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA) in BioScience Trends
- Vol. 5 (4) , 173-181
Abstract
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societiesKeywords
This publication has 24 references indexed in Scilit:
- Podocytes lose their footingNature, 2010
- Diabetic neuropathy: therapies on the horizonJournal of Pharmacy and Pharmacology, 2009
- Very high doses of valsartan provide renoprotection independently of blood pressure in a type 2 diabetic nephropathy rat modelNephrology, 2009
- Inhibition of renin angiotensin system decreases renal protein oxidative damage in diabetic ratsBiochemical and Biophysical Research Communications, 2008
- Renoprotective role of the vitamin D receptor in diabetic nephropathyKidney International, 2008
- Podocyte biology in diabetic nephropathyKidney International, 2007
- Activation of the renin–angiotensin system within podocytes in diabetesKidney International, 2007
- The intrarenal renin–angiotensin system and diabetic nephropathyTrends in Endocrinology & Metabolism, 2003
- The AT 1 -Type Angiotensin Receptor in Oxidative Stress and AtherogenesisCirculation, 2002
- Reactive oxygen species as glucose signaling molecules in mesangial cells cultured under high glucoseKidney International, 2000